Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

While there will no doubt be plenty of competing GLP-1 drugs and weight loss products in the market in the future ... The 10 ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

We have hardly begun to understand how inextricably our own health and safety are intertwined with those of our wild ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...

Lentils are full of fiber, which “slows down digestion,” once again reproducing the effect of the GLP-1 drugs, at a cost of ...

Ozempic, a Type 2 diabetes medication that has gained widespread attention, is known for its appetite-suppressing properties.

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...